Merck Sees $3.9 Million Bearish Put Sweep as Stock Trades Near 52-Week Highs

By TrendSpider Editor

A single unusual options contract totaling $3,924,450 in premium hit the tape for Merck & Company, Inc. (MRK) today, flagging a notable bearish bet as the stock trades at $141.88, down 0.62% on the session. The contract is a put targeting the $135 strike, suggesting the buyer is positioning for a me

Merck Sees $3.9 Million Bearish Put Sweep as Stock Trades Near 52-Week Highs

A single unusual options contract totaling $3,924,450 in premium hit the tape for Merck & Company, Inc. (MRK) today, flagging a notable bearish bet as the stock trades at $141.88, down 0.62% on the session. The contract is a put targeting the $135 strike, suggesting the buyer is positioning for a meaningful pullback from current levels. With MRK's 52-week range spanning $82.035 to $156.92, the stock sits in the upper half of its annual range, making this downside positioning worth watching closely.

Key Drivers of the MRK Stock Move

• Main Catalyst: One unusual put contract was flagged today on MRK with a $135 strike expiring November 20, 2026, carrying $3,924,450 in total premium. The contract printed with a size of 9,234 and an open interest ratio of 76%, indicating this is a largely new position rather than a close of existing exposure.
• Bull Case: MRK is currently trading at $141.88, sitting comfortably above the $135 put strike, meaning this contract is out of the money. The stock would need to decline more than 4.8% from current levels before the trade moves into the money, giving bulls meaningful buffer before this bet pays off for the options buyer.
• Bear Case: Nearly $3.9 million in premium committed to a single put contract is a significant directional bet. The 76% open interest ratio confirms this is a fresh position, signaling that sophisticated money is actively initiating downside protection or an outright bearish trade ahead of the November 20, 2026 expiration.

The forward setup for MRK warrants attention heading into the final stretch of 2026. The November 20, 2026 expiration gives the options buyer roughly six weeks for the thesis to play out, a window that could encompass any number of macro or company-specific catalysts. With MRK still holding well above its 52-week low of $82.035, the broader trend remains constructive, but the size of this single bearish print is difficult to ignore. Traders will want to monitor whether additional put activity accumulates at nearby strikes in the coming sessions, as a cluster of downside positioning would meaningfully reinforce this signal.

MRK Unusual Options Activity

One unusual contract was flagged for MRK on October 8, 2026:

• Type: Put | Strike: $135 | Expiry: November 20, 2026 | Volume: 9,234 | Open Interest: 76%

The sole flagged contract is a put, and with no call-side unusual activity recorded today, the options flow for MRK skews entirely bearish in today's session. The $3,924,450 premium tied to this single trade makes it one of the more consequential single-contract prints to watch in the large-cap pharma space this week.

MRK Seasonality

The October through November window has historically been an active period for pharmaceutical stocks, as year-end portfolio rebalancing and late-calendar clinical or regulatory announcements tend to drive volatility. A put expiring November 20, 2026 is precisely timed to capture that seasonal uncertainty.

MRK Relative Performance

MRK's current price of $141.88 represents a decline of 0.62% on the session, a modest underperformance on a day when broader markets absorb ongoing macro pressures. The stock's 52-week range of $82.035 to $156.92 reflects significant price history, and at current levels MRK is trading roughly 9.6% below its 52-week high, leaving room for either recovery toward prior highs or further deterioration toward the $135 put strike targeted in today's unusual flow.